BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30183456)

  • 21. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study.
    Kim SC; Glynn RJ; Giovannucci E; Hernández-Díaz S; Liu J; Feldman S; Karlson EW; Schneeweiss S; Solomon DH
    Ann Rheum Dis; 2015 Jul; 74(7):1360-7. PubMed ID: 24618265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
    Johnson DK; Reynolds KM; Poole BD; Montierth MD; Todd VM; Barnado A; Davis MF
    PLoS One; 2021; 16(1):e0243150. PubMed ID: 33481783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignancy in systemic lupus erythematosus.
    Abu-Shakra M; Gladman DD; Urowitz MB
    Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review on SLE and malignancy.
    Choi MY; Flood K; Bernatsky S; Ramsey-Goldman R; Clarke AE
    Best Pract Res Clin Rheumatol; 2017 Jun; 31(3):373-396. PubMed ID: 29224679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.
    Azrielant S; Tiosano S; Watad A; Mahroum N; Whitby A; Comaneshter D; Cohen AD; Amital H
    Immunol Res; 2017 Apr; 65(2):464-469. PubMed ID: 28091805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC).
    Oku K; Atsumi T; Akiyama Y; Amano H; Azuma N; Bohgaki T; Asanuma YF; Horita T; Hosoya T; Ichinose K; Kato M; Katsumata Y; Kawaguchi Y; Kawakami A; Koga T; Kohsaka H; Kondo Y; Kubo K; Kuwana M; Mimori A; Mimori T; Mimura T; Murakami K; Nakano K; Nakayamada S; Ogishima H; Ohmura K; Saito K; Sano H; Shibuya M; Takahashi Y; Takasaki Y; Takeuchi T; Tamura N; Tanaka Y; Tsuboi H; Tsunoda S; Yukawa N; Yamakawa N; Yamamoto K; Sumida T
    Mod Rheumatol; 2018 Jul; 28(4):642-648. PubMed ID: 29120258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
    Dreyer L; Faurschou M; Mogensen M; Jacobsen S
    Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.
    Smedby KE; Hjalgrim H; Askling J; Chang ET; Gregersen H; Porwit-MacDonald A; Sundström C; Akerman M; Melbye M; Glimelius B; Adami HO
    J Natl Cancer Inst; 2006 Jan; 98(1):51-60. PubMed ID: 16391371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using the American College of Rheumatology (ACR) and Systemic Lupus International Collaborating Clinics (SLICC) criteria to determine the diagnosis of systemic lupus erythematosus (SLE) in patients with subacute cutaneous lupus erythematosus (SCLE).
    Tiao J; Feng R; Carr K; Okawa J; Werth VP
    J Am Acad Dermatol; 2016 May; 74(5):862-9. PubMed ID: 26897388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.
    Bizzaro N; Villalta D; Giavarina D; Tozzoli R
    Autoimmun Rev; 2012 Dec; 12(2):97-106. PubMed ID: 22810055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
    Becker-Merok A; Nikolaisen C; Nossent HC
    Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of Epstein-Barr virus in systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, dermatomyositis) with associated lymphadenopathy: a study of 49 cases.
    Kojima M; Motoori T; Itoh H; Shimizu K; Iijima M; Tamaki Y; Murayama K; Ohno Y; Yoshida K; Masawa N; Nakamura S
    Int J Surg Pathol; 2005 Jul; 13(3):273-8. PubMed ID: 16086083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
    Sultan SM; Ioannou Y; Isenberg DA
    Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploring the links between systemic lupus erythematosus and cancer.
    Bernatsky S; Ramsey-Goldman R; Clarke A
    Rheum Dis Clin North Am; 2005 May; 31(2):387-402, viii-ix. PubMed ID: 15922152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity.
    Enocsson H; Sjöwall C; Wirestam L; Dahle C; Kastbom A; Rönnelid J; Wetterö J; Skogh T
    J Rheumatol; 2015 May; 42(5):817-25. PubMed ID: 25684763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-lymphoma hematological malignancies in systemic lupus erythematosus.
    Lu M; Bernatsky S; Ramsey-Goldman R; Petri M; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler EM; Yelin E; Bae SC; Wallace DJ; Jacobsen S; Dooley MA; Peschken CA; Alarcón GS; Nived O; Gottesman L; Criswell LA; Sturfelt G; Dreyer L; Lee JL; Clarke AE
    Oncology; 2013; 85(4):235-40. PubMed ID: 24107608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's lymphoma in systemic lupus erythematosus.
    Bernatsky S; Ramsey-Goldman R; Isenberg D; Rahman A; Dooley MA; Sibley J; Boivin JF; Joseph L; Armitage J; Zoma A; Clarke A
    Rheumatology (Oxford); 2007 May; 46(5):830-2. PubMed ID: 17255135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic lupus erythematosus and B-cell hematologic neoplasm.
    Xu Y; Wiernik PH
    Lupus; 2001; 10(12):841-50. PubMed ID: 11787873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology.
    Klein A; Polliack A; Gafter-Gvili A
    Leuk Res; 2018 Dec; 75():45-49. PubMed ID: 30458319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Cancer Risk Profile of Systemic Lupus Erythematosus Patients.
    Hardenbergh D; Naik R; Manno R; Azar A; Monroy Trujillo JM; Adler B; Haque U; Timlin H
    J Clin Rheumatol; 2022 Jan; 28(1):e257-e262. PubMed ID: 33657590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.